These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10971608)
21. Using gabapentin to treat neuropathic pain. Hays H; Woodroffe MA Can Fam Physician; 1999 Sep; 45():2109-12. PubMed ID: 10509223 [TBL] [Abstract][Full Text] [Related]
22. [Clinical studies on gabapentin in Switzerland]. Shokry A Praxis (Bern 1994); 1996 Jan; 85(4):94-8. PubMed ID: 8578060 [TBL] [Abstract][Full Text] [Related]
23. Effective treatment of orthostatic tremor with gabapentin. Evidente VG; Adler CH; Caviness JN; Gwinn KA Mov Disord; 1998 Sep; 13(5):829-31. PubMed ID: 9756154 [TBL] [Abstract][Full Text] [Related]
24. Gabapentin therapy for ocular opsoclonus-myoclonus restores eye movement communication in a patient with a locked-in syndrome. Pistoia F; Sarà M Neurorehabil Neural Repair; 2010 Jun; 24(5):493-4. PubMed ID: 19933381 [TBL] [Abstract][Full Text] [Related]
25. [Efficacy and tolerability of gabapentin in the treatment of patients with neuropathic pain. Results of an observational study involving 5620 patients]. Junker U; Brunnmüller U MMW Fortschr Med; 2003 Oct; 145(44):37. PubMed ID: 14655505 [No Abstract] [Full Text] [Related]
26. Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation. Rizzo V; Quartarone A; Bagnato S; Battaglia F; Majorana G; Girlanda P Neurol Sci; 2001 Jun; 22(3):229-32. PubMed ID: 11731875 [TBL] [Abstract][Full Text] [Related]
27. [Gabapentin--yet another antiepileptic agent for the treatment of neuropathic pain?]. Kamp-Jensen M; Werner MU Ugeskr Laeger; 2001 Jan; 163(4):454-8. PubMed ID: 11218787 [TBL] [Abstract][Full Text] [Related]
29. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Petroff OA; Rothman DL; Behar KL; Lamoureux D; Mattson RH Ann Neurol; 1996 Jan; 39(1):95-9. PubMed ID: 8572673 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and safety of gabapentin. Ramsay RE Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537 [TBL] [Abstract][Full Text] [Related]
31. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Kuzniecky R; Ho S; Pan J; Martin R; Gilliam F; Faught E; Hetherington H Neurology; 2002 Feb; 58(3):368-72. PubMed ID: 11839834 [TBL] [Abstract][Full Text] [Related]
32. Gabapentin abuse in a cocaine user: implications for treatment? Markowitz JS; Finkenbine R; Myrick H; King L; Carson WH J Clin Psychopharmacol; 1997 Oct; 17(5):423-4. PubMed ID: 9315994 [No Abstract] [Full Text] [Related]
33. Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus. Kanthasamy AG; Vu TQ; Yun RJ; Truong DD Eur J Pharmacol; 1996 Feb; 297(3):219-24. PubMed ID: 8666053 [TBL] [Abstract][Full Text] [Related]
34. Opsoclonus-myoclonus syndrome in patients with locked-in syndrome: a therapeutic porthole with gabapentin. Pistoia F; Conson M; Sarà M Mayo Clin Proc; 2010 Jun; 85(6):527-31. PubMed ID: 20511483 [TBL] [Abstract][Full Text] [Related]
39. Development of two stable oral suspensions for gabapentin. Nahata MC Pediatr Neurol; 1999 Mar; 20(3):195-7. PubMed ID: 10207927 [TBL] [Abstract][Full Text] [Related]
40. Stuttering caused by gabapentin. Nissani M; Sanchez EA Ann Intern Med; 1997 Mar; 126(5):410. PubMed ID: 9054293 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]